HIGHLIGHTS
- who: Top from the Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA have published the Article: Genomic alterations predictive of poor clinical outcomes in, in the Journal: (JOURNAL)
- how: This result was validated in two large pan-cancer cohorts with different clinical outcomes (PFS DSS OS).
- future: Future work should continue to investigate the prognostic values of mutations across cancers.
SUMMARY
Equal to 4% (≥4%) in 9,104 patients across 28 cancers. In the TCGA cohort, 37% of subjects had a TP53 mutation, and 68% had at . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.